| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 04, 2024 | Sale | $9.02 | 40,000 | 360,800 | 938,524 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 04, 2024 | Sale | $9.02 | 25,000 | 225,500 | 0 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 03, 2024 | Sale | $8.84 | 40,000 | 353,600 | 978,524 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 03, 2024 | Sale | $8.84 | 25,000 | 221,000 | 0 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 28, 2024 | Sale | $10.10 | 40,000 | 404,000 | 1,043,524 | Apr 01, 2024, 06:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 28, 2024 | Sale | $10.10 | 25,000 | 252,500 | 0 | Apr 01, 2024, 06:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.56 | 4,000 | 46,259 | 0 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.55 | 20,000 | 231,002 | 0 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Option Exercise | $7.96 | 76,243 | 607,065 | 1,144,843 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.56 | 1,000 | 11,562 | 0 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 15, 2024 | Option Exercise | $12.43 | 11,148 | 138,570 | 1,104,919 | Feb 16, 2024, 07:57 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 09, 2024 | Option Exercise | $10.09 | 3,233 | 32,621 | 1,116,067 | Feb 13, 2024, 06:55 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 07, 2024 | Sale | $6.57 | 79,522 | 522,481 | 822,975 | Feb 09, 2024, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Option Exercise | $5.96 | 62,103 | 370,304 | 822,578 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.49 | 1,000 | 9,494 | 0 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.51 | 4,000 | 38,029 | 0 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.51 | 20,000 | 190,240 | 0 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 06, 2023 | Option Exercise | $5.77 | 91,079 | 525,894 | 851,157 | Dec 08, 2023, 05:22 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 15, 2023 | Option Exercise | $7.18 | 16,913 | 121,435 | 819,907 | Nov 17, 2023, 05:50 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $3.96 | 68,427 | 270,806 | 873,997 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.14 | 1,000 | 5,137 | 0 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.14 | 4,000 | 20,564 | 0 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.11 | 20,000 | 102,294 | 0 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 04, 2023 | Sale | $5.59 | 91,044 | 508,525 | 902,541 | Oct 06, 2023, 06:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Option Exercise | $5.75 | 65,015 | 374,075 | 905,056 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.84 | 1,000 | 8,836 | 0 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.83 | 4,000 | 35,335 | 0 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.83 | 20,000 | 176,696 | 0 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 15, 2023 | Option Exercise | $9.19 | 16,913 | 155,430 | 873,806 | Aug 17, 2023, 06:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 02, 2023 | Sale | $9.76 | 104,939 | 1,024,095 | 955,734 | Aug 04, 2023, 05:51 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $7.86 | 63,068 | 495,476 | 947,628 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $11.83 | 1,000 | 11,828 | 764 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $11.79 | 4,000 | 47,172 | 3,150 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $11.76 | 20,000 | 235,266 | 15,570 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 07, 2023 | Option Exercise | $6.71 | 87,686 | 588,308 | 972,814 | Jun 09, 2023, 05:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 15, 2023 | Option Exercise | $5.60 | 11,661 | 65,302 | 941,564 | May 17, 2023, 06:16 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.92 | 1,000 | 4,915 | 0 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.91 | 4,000 | 19,623 | 0 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.90 | 20,000 | 98,036 | 0 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $3.63 | 64,323 | 233,261 | 986,298 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2022 | Sale | $7.39 | 18,500 | 136,669 | 582,805 | Apr 28, 2023, 04:32 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2023 | Sale | $3.67 | 44,577 | 163,538 | 960,037 | Apr 07, 2023, 05:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2023 | Sale | $6.64 | 40,000 | 265,672 | 906,710 | Apr 07, 2023, 05:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 09, 2023 | Sale | $7.77 | 15,000 | 116,621 | 938,787 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Option Exercise | $4.90 | 164,640 | 806,425 | 1,034,677 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.09 | 1,000 | 8,087 | 0 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.09 | 4,000 | 32,362 | 0 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.10 | 20,000 | 161,900 | 0 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.90 | 500 | 3,952 | 0 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.91 | 1,000 | 7,906 | 0 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.92 | 18,500 | 146,502 | 940,927 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.91 | 1,000 | 7,909 | 0 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 15, 2023 | Option Exercise | $8.44 | 1,346 | 11,360 | 940,927 | Feb 17, 2023, 05:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.21 | 500 | 4,604 | 0 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.21 | 1,000 | 9,208 | 0 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 01, 2023 | Option Exercise | $8.55 | 1,382 | 11,816 | 942,273 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.22 | 18,500 | 170,548 | 942,273 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.20 | 1,000 | 9,202 | 0 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 500 | 3,689 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 1,000 | 7,391 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 18,500 | 136,669 | 525,805 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 1,000 | 7,382 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.26 | 500 | 4,632 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $6.04 | 68,460 | 413,260 | 601,515 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 15, 2022 | Option Exercise | $11.86 | 5,751 | 68,207 | 570,265 | Nov 17, 2022, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,099 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.11 | 500 | 5,055 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,098 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $6.54 | 67,943 | 444,447 | 594,209 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $7.35 | 67,303 | 494,968 | 580,512 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,641 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 500 | 5,821 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,643 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,502 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $6.72 | 67,816 | 455,444 | 567,328 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,504 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 500 | 5,249 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 15, 2022 | Option Exercise | $12.96 | 5,751 | 74,533 | 536,078 | Aug 17, 2022, 06:32 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,448 | 0 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $6.27 | 68,075 | 426,941 | 560,154 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,447 | 0 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.44 | 500 | 4,722 | 0 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.06 | 500 | 4,531 | 0 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.07 | 1,000 | 9,070 | 0 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $6.05 | 68,364 | 413,478 | 547,518 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.07 | 1,000 | 9,068 | 0 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $4.50 | 70,940 | 319,266 | 537,458 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.34 | 1,000 | 6,341 | 0 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.34 | 500 | 3,172 | 0 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.35 | 1,000 | 6,346 | 0 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 16, 2022 | Option Exercise | $5.67 | 5,764 | 32,682 | 506,208 | May 18, 2022, 07:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 18,500 | 119,118 | 511,972 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 1,000 | 6,439 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $4.50 | 63,080 | 283,997 | 525,302 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 500 | 3,221 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $6.47 | 1,000 | 6,474 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.43 | 1,000 | 6,435 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $6.47 | 500 | 3,235 | 0 | May 06, 2022, 08:13 PM |
Menu